In this episode, we interview veterinary neurosurgeon Dr. Cris Falzone, a neurology specialist from Italy, on "How do I manage disc-associated wobbler syndrome (DAWS)?".

In this webinar, we interview Dr. Clare Rusbridge about Chiari-like malformation and syringomyelia. This is a complex developmental condition of the skull and craniocervical vertebrae, and is characterised by a conformational change and overcrowding of the brain and cervical spinal cord, particularly at the craniospinal junction. Obstruction to cerebrospinal fluid (CSF) channels can result in pain and a tendency for fluid cavitation of the spinal cord, called syringomyelia (SM).

A wonderful paper on this subject published by Dr Rusbridge can be found at the following link: https://bvajournals.onlinelibrary.wiley.com/doi/full/10.1136/inp.m1869

In this webinar, we interview Dr. Colin Driver (Dipl. ECVN) from Lumbry Park Veterinary Specialists on "How do I treat thoracolumbar myelopathies in Pug dogs". Colin has extensive experience on the subject of both imaging findings and surgical treatment of these complex conditions.

In this episode, Dr Lisa Bartner from Colorado State University discusses what is known on the use of cannabidiol for canine epilepsy. The anticonvulsant effect of cannabidiol (CBD), which has been confirmed by findings from animal models and human trials, has attracted the interest of veterinary practitioners and dog owners. We interviewed Dr. Bartner about the potential use of CBD for dogs that exhibit seizure activity.

In this session, we interview Dr. Mark Lowrie on paroxysmal dyskinesia, a movement disorder seen in both dogs and cats. These can be challenging presentations that can easily be confused with seizures but have some notable differences. Genetic advancements have been made in several breeds and there are some treatment options, all of which will be discussed in this webinar.

In this session, Dr. Ines Carrera talks about the MR imaging features of two common acute spinal cord diseases in dogs: Fibrocartilaginous embolic myelopathy or FCEM, and acute non-compressive nucleus pulposus extrusion or ANNPE. Can we reliably distinguish between the two conditions on MRI and can MRI provide negative prognostic indicators for recovery?

In this episode, our guest is Professor John Innes, orthopaedic specialist and Director of Movement Referrals in the UK. John and Laurent answer questions on the clinical approach to forelimb lameness and monoparesis to define where possible what is orthopaedic and what is neurologic, and to review what considerations for underlying causes we should have.

In this journal club webinar, Dr John Rossmeisl, Professor of neurology/neurosurgery at Virginia-Maryland, College of Veterinary Medicine discusses his article on the comparison between direct measurement of ICP and presumptive clinical and MRI indicators of intracranial hypertension (ICH) in dogs with brain tumors.

The objectives of this study were to: (a) evaluate the feasibility of direct ICP monitoring with a catheter strain-gauge microsensor transducer in dogs with brain tumors, (b) determine if direct ICP values were different between dogs with brain tumors and controls, and (c) determine if indirect MRI or clinical measures of presumed ICH could discriminate dogs with and without ICH.

In this session, Louise Clark Dipl. ECVAA and head of anaesthesia at Davies Veterinary Specialists, addresses the common problems encountered in anaesthesia of neurological patients and how to solve them. Using anesthesia in patients with brain disease, spinal disease, and neuromuscular disease can be a challenge as maintaining blood perfusion and oxygenation of the CNS can be more difficult and not without risk of making the patient worse. Tune in for tips on how to address the common issues and their underlying pathophysiology.

In this session, Dr. Fred Wininger, a veterinary neurologist and neurosurgeon at Charlotte Animal Referral & Emergency Hospital, owner of 3D Veterinary Printing LLC, and Adjunct Professor at the University of Missouri, talks about the utility of 3D printing for neurosurgical procedures. A how, why, and what presentation for all you need to know on what is quickly becoming a vital process in optimizing successful case management.